 Connection
Mark Boguniewicz to Drug Therapy, Combination
This is a "connection" page, showing publications Mark Boguniewicz has written about Drug Therapy, Combination.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.122 |
|
|
|
-
Chu AWL, Wen A, Guyatt GH, Rao M, Bakaa L, Zhao IX, Roldan Y, Spergel JM, LeBovidge J, Boguniewicz M, Martin SA, Lind ML, Silverberg JI, Lio PA, Asiniwasis RN, Wang J, De Benedetto A, Greenhawt M, Wheeler KE, Ong PY, Frazier WT, Nelson H, O'Brien M, Capozza K, Begolka WS, Gardner DD, Schneider LC, Chu DK. Antihistamines for atopic dermatitis (eczema): systematic review and network meta-analysis of randomised trials. BMJ. 2026 Jul 29; 394:e100163.
Score: 0.049
-
Boguniewicz M. Combination therapy and new directions for managing atopic dermatitis. Allergy Asthma Proc. 2002 Jul-Aug; 23(4):243-6.
Score: 0.037
-
Sigurgeirsson B, Boznanski A, Todd G, Vertruyen A, Schuttelaar ML, Zhu X, Schauer U, Qaqundah P, Poulin Y, Kristjansson S, von Berg A, Nieto A, Boguniewicz M, Paller AS, Dakovic R, Ring J, Luger T. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 2015 Apr; 135(4):597-606.
Score: 0.022
-
Spergel JM, Boguniewicz M, Paller AS, Hebert AA, Gallagher PR, McCormick C, Parneix-Spake A, Hultsch T. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. Br J Dermatol. 2007 Aug; 157(2):378-81.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|